156 related articles for article (PubMed ID: 38381555)
1. Lipid-Encapsulated mRNAs Encoding Complex Fusion Proteins Potentiate Antitumor Immune Responses.
Shuptrine CW; Chen Y; Miriyala J; Lenz K; Moffett D; Nguyen TA; Michaux J; Campbell K; Smith C; Morra M; Rivera-Molina Y; Murr N; Cooper S; McGuire A; Makani V; Oien N; Zugates JT; de Silva S; Schreiber TH; de Picciotto S; Fromm G
Cancer Res; 2024 May; 84(10):1550-1559. PubMed ID: 38381555
[TBL] [Abstract][Full Text] [Related]
2. Engineered mRNA-expressed bispecific antibody prevent intestinal cancer via lipid nanoparticle delivery.
Wu L; Wang W; Tian J; Qi C; Cai Z; Yan W; Xuan S; Shang A
Bioengineered; 2021 Dec; 12(2):12383-12393. PubMed ID: 34895063
[TBL] [Abstract][Full Text] [Related]
3. mRNAs encoding self-DNA reactive cGAS enhance the immunogenicity of lipid nanoparticle vaccines.
Zhivaki D; Gosselin EA; Sengupta D; Concepcion H; Arinze C; Chow J; Nikiforov A; Komoroski V; MacFarlane C; Sullivan C; Kagan JC
mBio; 2023 Nov; 14(6):e0250623. PubMed ID: 37937842
[TBL] [Abstract][Full Text] [Related]
4. Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria.
Meulewaeter S; Aernout I; Deprez J; Engelen Y; De Velder M; Franceschini L; Breckpot K; Van Calenbergh S; Asselman C; Boucher K; Impens F; De Smedt SC; Verbeke R; Lentacker I
J Control Release; 2024 Jun; 370():379-391. PubMed ID: 38697317
[TBL] [Abstract][Full Text] [Related]
5. mRNA-encoded, constitutively active STING
Tse SW; McKinney K; Walker W; Nguyen M; Iacovelli J; Small C; Hopson K; Zaks T; Huang E
Mol Ther; 2021 Jul; 29(7):2227-2238. PubMed ID: 33677092
[TBL] [Abstract][Full Text] [Related]
6. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
[TBL] [Abstract][Full Text] [Related]
7. Delivery and Expression of mRNA in the Secondary Lymphoid Organs Drive Immune Responses to Lipid Nanoparticle-mRNA Vaccines after Intramuscular Injection.
Takanashi A; Pouton CW; Al-Wassiti H
Mol Pharm; 2023 Aug; 20(8):3876-3885. PubMed ID: 37491979
[TBL] [Abstract][Full Text] [Related]
8. Lipid nanoparticle-based mRNA candidates elicit potent T cell responses.
Zeng Y; Escalona-Rayo O; Knol R; Kros A; Slütter B
Biomater Sci; 2023 Jan; 11(3):964-974. PubMed ID: 36537916
[TBL] [Abstract][Full Text] [Related]
9. Investigations into mRNA Lipid Nanoparticles Shelf-Life Stability under Nonfrozen Conditions.
Reinhart AG; Osterwald A; Ringler P; Leiser Y; Lauer ME; Martin RE; Ullmer C; Schumacher F; Korn C; Keller M
Mol Pharm; 2023 Dec; 20(12):6492-6503. PubMed ID: 37975733
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy of Tumor RNA-Loaded Lipid Nanoparticles Against Hepatocellular Carcinoma.
Zhang Y; Xie F; Yin Y; Zhang Q; Jin H; Wu Y; Pang L; Li J; Gao J
Int J Nanomedicine; 2021; 16():1553-1564. PubMed ID: 33658783
[TBL] [Abstract][Full Text] [Related]
11. Targeted lipid nanoparticle delivery of calcitriol to human monocyte-derived macrophages in vitro and in vivo: investigation of the anti-inflammatory effects of calcitriol.
Rafique A; Etzerodt A; Graversen JH; Moestrup SK; Dagnæs-Hansen F; Møller HJ
Int J Nanomedicine; 2019; 14():2829-2846. PubMed ID: 31114197
[TBL] [Abstract][Full Text] [Related]
12. Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice.
Ramos da Silva J; Bitencourt Rodrigues K; Formoso Pelegrin G; Silva Sales N; Muramatsu H; de Oliveira Silva M; Porchia BFMM; Moreno ACR; Aps LRMM; Venceslau-Carvalho AA; Tombácz I; Fotoran WL; Karikó K; Lin PJC; Tam YK; de Oliveira Diniz M; Pardi N; de Souza Ferreira LC
Sci Transl Med; 2023 Mar; 15(686):eabn3464. PubMed ID: 36867683
[TBL] [Abstract][Full Text] [Related]
13. PD-1 blockade synergizes with intratumoral vaccination of a therapeutic HPV protein vaccine and elicits regression of tumor in a preclinical model.
Peng S; Tan M; Li YD; Cheng MA; Farmer E; Ferrall L; Gaillard S; Roden RBS; Hung CF; Wu TC
Cancer Immunol Immunother; 2021 Apr; 70(4):1049-1062. PubMed ID: 33108473
[TBL] [Abstract][Full Text] [Related]
14. Lipid Nanoparticle-mRNA Formulations for Therapeutic Applications.
Wang C; Zhang Y; Dong Y
Acc Chem Res; 2021 Dec; 54(23):4283-4293. PubMed ID: 34793124
[TBL] [Abstract][Full Text] [Related]
15. Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA.
Ball RL; Hajj KA; Vizelman J; Bajaj P; Whitehead KA
Nano Lett; 2018 Jun; 18(6):3814-3822. PubMed ID: 29694050
[TBL] [Abstract][Full Text] [Related]
16. Tumor-activated IL-2 mRNA delivered by lipid nanoparticles for cancer immunotherapy.
Jiang Y; Zhang Y; Liu C; Liu J; Xue W; Wang Z; Li X
J Control Release; 2024 Apr; 368():663-675. PubMed ID: 38492862
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral delivery of IL-12 and IL-27 mRNA using lipid nanoparticles for cancer immunotherapy.
Liu JQ; Zhang C; Zhang X; Yan J; Zeng C; Talebian F; Lynch K; Zhao W; Hou X; Du S; Kang DD; Deng B; McComb DW; Bai XF; Dong Y
J Control Release; 2022 May; 345():306-313. PubMed ID: 35301053
[TBL] [Abstract][Full Text] [Related]
18. Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with a vitamin E scaffold and the KALA peptide for use as an ex vivo dendritic cell-based cancer vaccine.
Tateshita N; Miura N; Tanaka H; Masuda T; Ohtsuki S; Tange K; Nakai Y; Yoshioka H; Akita H
J Control Release; 2019 Sep; 310():36-46. PubMed ID: 31386869
[TBL] [Abstract][Full Text] [Related]
19. CD40 Enhances Type I Interferon Responses Downstream of CD47 Blockade, Bridging Innate and Adaptive Immunity.
de Silva S; Fromm G; Shuptrine CW; Johannes K; Patel A; Yoo KJ; Huang K; Schreiber TH
Cancer Immunol Res; 2020 Feb; 8(2):230-245. PubMed ID: 31852716
[TBL] [Abstract][Full Text] [Related]
20. Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8
Chen J; Ye Z; Huang C; Qiu M; Song D; Li Y; Xu Q
Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2207841119. PubMed ID: 35969778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
